Immunic's market cap is currently ―. The company's EPS TTM is $-2.113; its P/E ratio is -0.57; Immunic is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -21.57M	$ -22.77M	$ -24.00M	$ -25.27M	$ -57.17M
EBITDA	$ -21.55M	$ -22.73M	$ -23.98M	$ -25.24M	$ -57.15M
Net Income Common Stockholders	$ -21.57M	$ -22.77M	$ -24.00M	$ -25.27M	$ -56.47M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 46.67M	$ 59.70M	$ 77.30M	$ 97.11M	$ 116.37M
Total Assets	$ 54.30M	$ 66.98M	$ 88.75M	$ 108.58M	$ 127.75M
Total Debt	$ 639.00K	$ 789.00K	$ 1.21M	$ 1.35M	$ 992.00K
Net Debt	$ -46.03M	$ -58.91M	$ -76.09M	$ -95.76M	$ -115.38M
Total Liabilities	$ 25.37M	$ 18.57M	$ 19.45M	$ 17.65M	$ 14.07M
Stockholders Equity	$ 28.93M	$ 48.41M	$ 69.23M	$ 91.17M	$ 113.68M
Cash Flow	-
Free Cash Flow	$ -23.99M	$ -7.56M	$ -20.00M	$ -19.62M	$ -15.10M
Operating Cash Flow	$ -14.03M	$ -17.31M	$ -19.98M	$ -19.51M	$ -15.10M
Investing Cash Flow	$ -165.00K	$ -44.00K	$ 4.34M	$ 5.33M	$ -9.63M
Financing Cash Flow	$ 604.00K	$ 282.00K	$ 96.00K	$ 51.00K	$ 56.04M

Currency in USD

Immunic Earnings and Revenue History

Income Statement >

Immunic Debt to Assets

Balance Sheet >

Immunic Cash Flow

Cash Flow >

Immunic Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing